Pear Therapeutics loses 97% of its market capitalization since 2021, explores strategic alternatives

Pear Ther­a­peu­tics explor­ing sale, oth­er ‘strate­gic alter­na­tives’ (Mobi­Health News): Pre­scrip­tion dig­i­tal ther­a­peu­tics com­pa­ny Pear Ther­a­peu­tics is explor­ing “strate­gic alter­na­tives,” includ­ing a pos­si­ble com­pa­ny sale, merg­er or acqui­si­tion. In a press release, the com­pa­ny said it hired a finan­cial advi­sor to look into actions that could “max­i­mize share­hold­er val­ue.” That includes a poten­tial sale, M&A, divestiture…

Read More

Pear Therapeutics raises $175M and goes public via SPAC deal raising the profile of prescription digital therapeutics

Dig­i­tal health firm Pear goes pub­lic, rais­ing $175 mil­lion (phar­mafo­rum): Pear will make its debut on the exchange today after com­bin­ing with Thim­ble Point – a spe­cial pur­pose acqui­si­tion com­pa­ny (SPAC) – in a deal that side­stepped the con­ven­tion­al ini­tial pub­lic offer­ing (IPO) route and has pro­pelled its val­u­a­tion to around $1.6 bil­lion … Pear specialises…

Read More

Integrating music, movement and stroke rehabilitation, MedRhythms raises $25M to develop and commercialize digital therapeutic

MedRhythms rais­es 25m to get patients back in tune after a stroke (TechCrunch): MedRhythms secured $25 mil­lion in Series B fund­ing to advance its dig­i­tal ther­a­py plat­form aimed at mea­sur­ing and improv­ing someone’s abil­i­ty to walk after they have expe­ri­enced a neu­ro­log­ic injury or dis­ease … Com­pa­ny co-founder and CEO Bri­an Har­ris was a neu­ro­log­ic music…

Read More

Prescription software firm Pear Therapeutics to go public via $1.6 billion SPAC deal, harnessing 3 FDA-authorized products and 14 candidates

Pear Ther­a­peu­tics to Go Pub­lic in Rough­ly $1.6 Bil­lion SPAC Deal (The Wall Street Jour­nal): Med­ical tech­nol­o­gy com­pa­ny Pear Ther­a­peu­tics Inc. has agreed to go pub­lic by merg­ing with a blank-check com­pa­ny with ties to the Pritzk­er Vlock Fam­i­ly Office, bet­ting on the grow­ing role of pre­scrip­tion dig­i­tal ther­a­peu­tics. The pro­posed merg­er would give the…

Read More

Akili Interactive Labs raises $160M in equity and debt to transform cognitive healthcare via prescription videogame treatments

Akili rais­es $110m to build its dig­i­tal ther­a­peu­tics pipeline (phar­mafo­rum): Endeav­or­Rx became the first and so far only approved pre­scrip­tion video game treat­ment in the US when it was cleared by the FDA last year to treat atten­­tion-deficit hyper­ac­tiv­i­ty dis­or­der (ADHD), and has also been giv­en a green light in Europe.

Read More

Ohio joins Indiana and Kentucky in funding Pear Therapeutics’ digital addiction treatments

Ohio is third state to fund Pear’s dig­i­tal ther­a­peu­tics to tack­le addic­tion (phar­mafo­rum): The com­pa­ny has been push­ing for more reim­burse­ment of its three mar­ket­ed DTx prod­ucts in the US fol­low­ing a first FDA approval in 2017. Pear said that the Ohio Depart­ment of Men­tal Health and Addic­tion Ser­vices (OhioMHAS) and Recov­ery­Ohio are pro­vid­ing access to…

Read More